Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.

ABSTRACT: Rivaroxaban or placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer: a randomized, double blind, placebo-controlled study.

DISEASE(S): Prevention Of Venous Thromboembolism,Venous Thromboembolism,Thromboembolism

PROVIDER: 2236844 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR